• Multimodal Management of Canine Osteoarthritis, Second Edition takes an evidence-based approach to the canine patient with osteoarthritis, pursuing the objective of the best available medicine by a variety of means: multiple drugs, agents, adjuncts and delivery methods. Appreciating that surgical intervention may initially be required, particularly for stabilizing a joint, the major focus in this work is the conservative management of osteoarthritis. A clear and visual approach is taken with the overlapping of two three-pointed triangles of management: medical and non-medical.

    The completely updated new edition offers a major new chapter on Regenerative Medicine in collaboration with Drs Sherman Canapp and Brittany Jean Carr. It is recommended for any small animal veterinary practitioner, as well as researchers and students of the RCVS CertAVP

  • Preface. Disclaimer. Abbreviations. Pain and Lameness. Pain. Diagnosis of osteoarthritis. Anamnesis. Examination. The orthopedic examination. Diagnostic imaging. Arthroscopy. Arthrocentesis. Quick tips.

    Osteoarthritis: the disease. Definition. Joint structures. Inflammation in OA. The ‘pain pathway’. Morphological changes with OA.

    Multimodal Management for Canine Osteoarthritis. Quality of evidence. Background. Medicinal management. Nonsteroidal anti-inflammatory drugs Prostaglandin E2 recptor antagonists. Disease modifying osteoarthritic agents. Nutraceuticals. 51 Adjuncts. Acupuncture. Radiosynoviorthesis. Drug classes for multimodal use. Nonmedicinal management. Diet. Surgical intervention. Summary.

    Physical Rehabilitation in the Treatment of Osteoarthritis. Introduction. Environmental modification. Pain pathophysiology related to physical rehabilitation. Cryotherapy. Thermotherapy. Therapeutic exercises. Other techniques. Multimodal case studies.

    REGENERATIVE MEDICINE FOR MULTIMODAL MANAGEMENT OF OSTEOARTHRITIS. Platlet rich plasma. Stem cell therapy. Adepose derived stem cell therapy. Bone marrow derived stem cell therapy. Recommendations following stem cell therapy. Interleukin-1 receptor antagonist protein. Other intra-articular therapies. Corticosteroids.

    References. Index.

  • Dr. Fox received his M.S. and veterinary medical degrees from the University of Illinois, and M.B.A. (entrepreneurialism and new ventures) and Ph.D. (pain management) degrees from Massey University in New Zealand. Dr. Fox served on the faculty of the veterinary teaching hospital at Mississippi State University, as product manager at Pioneer Hi-Bred International, senior lecturer in companion animal orthopedic surgery at Massey University, senior veterinary specialist at Pfizer Animal Health, and Director of Pain Management at Novartis Animal Health.

    Prior to his career in veterinary medicine, Dr. Fox graduated with a B.S. in mechanical engineering from the U.S. Naval Academy, and flew more than 300 combat missions as a naval aviator in Vietnam while serving concurrently as Officer of the Deck aboard the USS Enterprise. He enjoys dual U.S. and New Zealand citizenship, is a certified small animal surgical specialist in New Zealand, president of the Veterinary Orthopedic society for 2004, an Adjunct Assistant Professor at the University of Illinois, advisor to the University of Tennessee Pain Center, founding member of the Companion Animal Pain Management Consortium Leadership Council and a Fellow of the New Zealand Institute of Management.

    Dr. Fox has authored more than 80 professional publications, 2 textbooks, 5 textbook chapters and 2 interactive CD/DVDs.

Veterinary Clinics of North America
info